New York Life Investment Management’s Scansource SCSC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-8,339
Closed -$367K 1243
2024
Q1
$367K Sell
8,339
-3,006
-26% -$122K ﹤0.01% 1044
2023
Q4
$449K Sell
11,345
-351
-3% -$11.8K ﹤0.01% 907
2023
Q3
$355K Sell
11,696
-1,843
-14% -$55.3K ﹤0.01% 995
2023
Q2
$400K Sell
13,539
-2,416
-15% -$69.8K ﹤0.01% 1006
2023
Q1
$486K Sell
15,955
-350
-2% -$10.9K 0.01% 785
2022
Q4
$476K Buy
16,305
+1,838
+13% +$54.5K 0.01% 961
2022
Q3
$382K Buy
14,467
+1,063
+8% +$32.1K ﹤0.01% 979
2022
Q2
$417K Buy
+13,404
New +$470K ﹤0.01% 906

Other funds holding SCSC

New York Life Investment Management's SCSC Position: Q2 2024 in Review

New York Life Investment Management sold out of Scansource (SCSC) in Q2 2024, closing a stake of 8,339 shares — an estimated $367K sold.

New York Life Investment Management first reported a position in SCSC in Q2 2022 and held it in 8 quarters. The position peaked at $486K in Q1 2023. 179 funds tracked by Wall St. Rank hold SCSC as of Q2 2024.

  • New York Life Investment Management reported no remaining Scansource position as of Q2 2024 after selling out during the quarter.
  • New York Life Investment Management sold 8,339 Scansource shares in Q2 2024, an estimated $367K.
  • New York Life Investment Management first reported a position in Scansource in Q2 2022 and held it in 8 quarters.
  • New York Life Investment Management's Scansource position peaked at $486K in Q1 2023.
  • 179 funds tracked by Wall St. Rank held Scansource as of Q2 2024.

Based on New York Life Investment Management's 13F filing for Q2 2024, filed 5 Aug 2024.